Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.
Adeel M KhanThita ChiasakulRobert A ReddRushad PatellEllen P McCarthyDonna S NeubergJeffrey I ZwickerPublished in: PLoS medicine (2022)
In this analysis of a population-based registry, warfarin was associated with prolonged overall survival compared to DOACs for treatment of cancer-associated VTE.